Amalgamated Bank’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Hold |
26,263
| – | – | ﹤0.01% | 1653 |
|
|
2025
Q1 | $170K | Sell |
26,263
-300
| -1% | -$1.94K | ﹤0.01% | 1569 |
|
|
2024
Q4 | $195K | Sell |
26,563
-172
| -0.6% | -$1.26K | ﹤0.01% | 1580 |
|
|
2024
Q3 | $200K | Buy |
26,735
+995
| +4% | +$7.44K | ﹤0.01% | 1585 |
|
|
2024
Q2 | $229K | Sell |
25,740
-2,032
| -7% | -$18.1K | ﹤0.01% | 1547 |
|
|
2024
Q1 | $281K | Sell |
27,772
-4,698
| -14% | -$47.5K | ﹤0.01% | 1503 |
|
|
2023
Q4 | $327K | Sell |
32,470
-1,159
| -3% | -$11.7K | ﹤0.01% | 1610 |
|
|
2023
Q3 | $315K | Buy |
33,629
+2,511
| +8% | +$23.5K | ﹤0.01% | 1610 |
|
|
2023
Q2 | $763K | Sell |
31,118
-423
| -1% | -$10.4K | 0.01% | 1245 |
|
|
2023
Q1 | $734K | Sell |
31,541
-2,508
| -7% | -$58.4K | 0.01% | 1242 |
|
|
2022
Q4 | $862K | Buy |
34,049
+228
| +0.7% | +$5.77K | 0.01% | 1207 |
|
|
2022
Q3 | $652K | Buy |
33,821
+704
| +2% | +$13.6K | 0.01% | 1297 |
|
|
2022
Q2 | $843K | Buy |
33,117
+23,314
| +238% | +$593K | 0.01% | 1210 |
|
|
2022
Q1 | $252K | Sell |
9,803
-776
| -7% | -$19.9K | ﹤0.01% | 1846 |
|
|
2021
Q4 | $443K | Sell |
10,579
-115
| -1% | -$4.82K | ﹤0.01% | 1639 |
|
|
2021
Q3 | $465K | Sell |
10,694
-659
| -6% | -$28.7K | ﹤0.01% | 1617 |
|
|
2021
Q2 | $537K | Buy |
11,353
+3,725
| +49% | +$176K | ﹤0.01% | 1603 |
|
|
2021
Q1 | $391K | Sell |
7,628
-744
| -9% | -$38.1K | 0.01% | 1115 |
|
|
2020
Q4 | $224K | Buy |
8,372
+41
| +0.5% | +$1.1K | 0.01% | 1388 |
|
|
2020
Q3 | $286K | Buy |
8,331
+922
| +12% | +$31.7K | 0.01% | 1133 |
|
|
2020
Q2 | $304K | Buy |
+7,409
| New | +$304K | 0.01% | 1096 |
|